Growth and growth hormone therapy in subjects with mulibrey nanism

Pediatrics

Volumn 120, Issue 1, 2007, Pages

  Karlberg, Niklas ^a,b   Jalanko, Hannu ^a,b   Lipsanen Nyman, Marita ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b BIOMEDICUM HELSINKI   (Finland)

Author keywords

Fetal growth restriction; Genetic disease; Growth failure; Growth hormone treatment; Insulin resistance

Indexed keywords

RECOMBINANT GROWTH HORMONE;

BODY HEIGHT; BODY WEIGHT; BONE MATURATION; CHILD; CHILD GROWTH; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; FEMALE; GLUCOSE METABOLISM; GROWTH DISORDER; HORMONAL THERAPY; HUMAN; INFANT; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; MULIBREY NANISM; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PUBERTY; REVIEW; SMALL FOR DATE INFANT;

BLOOD GLUCOSE; BODY HEIGHT; BODY WEIGHT; CHILD; DWARFISM; FEMALE; GROWTH; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; PUBERTY;

EID: 34447121886     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-2686     Document Type: Review

References (43)

1. Perheentupa J, Autio S, Leisti S, Raitta C, Tuuteri L. Mulibrey nanism, an autosomal recessive syndrome with pericardial constriction. Lancet. 1973;2(7825):351-355
2. Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet. 2004;41:92-98
3. Avela K, Lipsanen-Nyman M, Idänheimo N, et al. Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism. Nat Genet. 2000;25:298-301
4. Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki AE. The. TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet. 2002;70:1215-1228
5. Lehesjoki AE, Reed VA, Mark Gardiner R, Greene ND. Expression of MUL, a gene encoding a novel RBCC family ring-finger protein, in human and mouse embryogenesis. Mech Dev. 2001;108:221-225
6. Kallijärvi J, Hämäläinen R, Karlberg N, Sainio K, Lehesjoki AE. Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues. Histochem Cell Biol. 2006;126:325-334
7. Kallijärvi J, Lahtinen U, Hämäläinen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res. 2005;308:146-155
8. Borden KL. RING domains: master builders of molecular scaffolds? J Mol Biol. 2000;295:1103-1112
9. Hämäläinen RH, Avela K, Lambert J, et al. Genomic structure and novel mutations in the TRIM37 gene in mulibrey nanism. Hum Mutat. 2004;23:522-544
10. Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijärvi A, Kupari M. Mulibrey heart disease: clinical manifestations, long-term course and results of pericardiectomy in a series of 49 patients born before 1985. Circulation. 2003;107:2810-2815
11. Karlberg N, Jalanko H, Kallijärvi J, Lehesjoki AE, Lipsanen-Nyman M. Insulin resistance syndrome in subjects with mutated RING finger protein TRIM37. Diabetes. 2005;54:3577-3581
12. Boguszewski M, Albertsson-Wikland K, Aronsson S, et al. Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial. Acta Paediatr. 1998;87:257-263
13. Azcona C, Albanese A, Bareille P, Stanhope R. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Silver-Russell. Horm Res. 1998;50:22-27
14. de Zegher F, Hokken-Koelega A. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics. 2005;115(4). Available at: www.pediatrics.org/cgi/content/full/115/4/e458
15. Kelnar CJH. Growth hormone therapy for syndromic disorders. Clin Endocrinol (Oxf). 2003;59:12-21
16. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press; 1950:256
17. Sorva R, Perheentupa J, Tolppanen EM. A novel format for a growth chart. Acta Padiatr Scand. 1984;73:527-529
18. Pere A. Comparison of two methods of transforming height and weight to normality. Ann Hum Biol. 2000;27:35-45
19. Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth curves in Finland [in Finnish]. Duodecim. 1989;105:1540-1546
20. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1979;51:170-179
21. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr. 1994;83:64-70
22. Kliegman RM, Das UG. Intrauterine growth retardation. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine, Diseases of the Fetus and Infant. 7th ed. St Louis, MO: Mosby; 2002:228-262
23. Wit JM, Finken MJ, Rijken M, de Zegher F. Preterm growth restraint: a paradigm that unifies intrauterine growth retardation and preterm extrauterine growth retardation and has implications for the small-for-gestational-age indication in growth hormone therapy. Pediatrics. 2006;117(4). Available at: www.pediatrics.org/cgi/content/full/117/4/e793
24. Niklasson A, Engström E, Hård AL, Albertsson-Wikland K, Hellstöm A. Growth in very preterm children: a longitudinal study. Pediatr Res. 2003;54:899-905
25. Finken MJJ, Dekker FW, de Zegher F, Wit JM; Dutch Project on Preterm and Small-for-Gestational-age-19 Collaborative Study Group. Long-term height gain of prematurely born children with neonatal growth restraint: parallellism with the growth pattern of short children born small for gestational age. Pediatrics. 2006;118:640-643
26. Myllärniemi S, Koski K, Perheentupa J. Craniofacial and dental study of mulibrey nanism. Cleft Palate J. 1978;15:369-377
27. Gibson AT, Carney S, Wales JKH. Growth and the premature baby. Horm Res. 2006;65:75-81
28. Boguszewski M, Rosberg S, Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab. 1995;80:2599-2606
29. de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-1 and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf). 1994;41:621-630
30. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: The role of the mother, placenta, and fetus. Endocr Rev. 2006;27:141-169
31. Gircquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet. 2005;37:1003-1007
32. Hagenäs L, Hertel T. Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children. Horm Res. 2003;60:65-70
33. Dahlgren J, Wikland KA. Final height in short children born small for gestational age treated with growth hormone. Pediatr Res. 2005;57:216-222
34. van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age. J Clin Endocrinol Metab. 2003;88:347-353
35. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. Insulin regulates insulin like growth factor-1 mRNA in rat hepatocytes. Am J Physiol. 1991;260:846-851
36. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J. 1991;278:609-619
37. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998;83:3558-3562
38. Ibanez L, Ong K, Valls C, Marcos MV, Dunger DB, De Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab. 2006;91:2068-2073
39. Karlberg S, Tiitinen A, Lipsanen-Nyman M. Failure of sexual maturation in mulibrey nanism. N Engl J Med. 2004;351:2559-2560
40. Cutler GB Jr The role of estrogen in bone growth and maturation during childhood and adolescents. J Steroid Biochem Molec Biol. 1997;61:141-144
41. Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling. Curr Opin Clin Nut Metab Care. 2004;7:249-254
42. van Kerkhofen P, Strous GJ. The ubiqutin-proteasome pathway and the regulation of growth hormone receptor availability. Mol Cell Endocrinol. 2002;197:143-151
43. Huber C, Dias-Santaga D, Glaser A, et al. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet. 2005;37:1119-1124